SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?


To: Mike McFarland who wrote (551)10/27/2008 6:19:10 PM
From: Mike McFarlandRead Replies (1) | Respond to of 557
 
Targeted Genetics Announces Presentation of Data From Completed Phase 1/2 tgAAC94 Trial at American College of Rheumatology
Study Achieves Primary Endpoint of Safety and Tolerability; Improvement in Patient-Reported Outcome Measures Observed
ir.targen.com